Hereditary diffuse gastric cancer: updated clinical practice guidelines

Vanessa Blair(University of Auckland), Maybelle McLeod(Whakauae Research (New Zealand)), Fátima Carneiro(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Daniel G. Coit(Memorial Sloan Kettering Cancer Center), Johanna L D'Addario(Hereditary Disease Foundation), Jolanda M. van Dieren(The Netherlands Cancer Institute), Kirsty L Harris, Nicoline Hoogerbrugge(Radboud University Nijmegen), Carla Oliveíra(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Rachel S. van der Post(Radboud University Nijmegen), Julie Arnold(Auckland City Hospital), Patrick R. Benusiglio(Sorbonne Université), Tanya M. Bisseling(Radboud University Nijmegen), Alex Boussioutas(The Royal Melbourne Hospital), Annemieke Cats(The Netherlands Cancer Institute), Amanda Charlton(Auckland City Hospital), Karen E Chelcun Schreiber(Hereditary Disease Foundation), Jeremy L. Davis(National Institutes of Health), Massimiliano di Pietro(University of Cambridge), Rebecca C. Fitzgerald(University of Cambridge), James M. Ford(Stanford University), Kimberley Gamet(Auckland City Hospital), Irene Gullo(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Richard Hardwick(National Health Service), David G. Huntsman(University of British Columbia), Pardeep Kaurah(BC Cancer Agency), Sonia S. Kupfer(University of Chicago), Andrew Latchford(St. Mark's Hospital), Paul F. Mansfield(The University of Texas MD Anderson Cancer Center), Takeshi Nakajima(The Cancer Institute Hospital), Susan Parry(Auckland City Hospital), Jeremy Rossaak(Tauranga Hospital), Haruhiko Sugimura(Hamamatsu University School of Medicine), Magali Svrcek(Sorbonne Université), Marc Tischkowitz(University of Cambridge), Toshikazu Ushijima(National Cancer Centre Japan), Hidetaka Yamada(Hamamatsu University School of Medicine), Han‐Kwang Yang(Seoul National University Hospital), Adrian Claydon(Tauranga Hospital), Joana Figueiredo(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Karyn Paringatai(University of Otago), Raquel Seruca(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Nicola Bougen‐Zhukov(University of Otago), Tom P. Brew(University of Otago), Simone Busija, Patrı́cia Carneiro(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Lynn DeGregorio, Helen Fisher, Erin R. Gardner(Whakauae Research (New Zealand)), Tanis Godwin(University of Otago), Katharine Nichole Holm(University of California, Davis), Bostjan Humar(University Hospital of Zurich), C.J. Lintott(Christchurch Hospital), Elizabeth C. Monroe, Mark D Muller, Enrique Norero(Pontificia Universidad Católica de Chile), Yasmin Nouri(University of Otago), Joana Paredes(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), João Sanches(INESC TEC), Emily Schulpen(University of Otago), Ana Sofia Ribeiro(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Andrew Sporle(University of Otago), James Whitworth(University of Cambridge), Liying Zhang(University of California, Los Angeles), Anthony E. Reeve(University of Otago), Parry Guilford(University of Otago)
The Lancet Oncology
August 1, 2020
Cited by 474Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis